Exozymes Inc (EXOZ)

$10.73 -1.32 (-10.95%)
Market Cap 100.83M
Revenue (ttm) 0.00
Net Income (ttm) -5.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 22,000
Avg Vol 12,546
Day's Range N/A - N/A
Shares Out 8.37M
Stochastic %K 11%
Beta N/A
Analysts Strong Buy
Price Target N/A

Latest News on EXOZ

Bringing clarity and precision to the cell-free space by introducing exozymes

Apr 21, 2025, 4:10 PM EDT - 4 days ago

Bringing clarity and precision to the cell-free space by introducing exozymes

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Apr 10, 2025, 4:30 PM EDT - 15 days ago

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

Apr 2, 2025, 4:10 PM EDT - 23 days ago

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Apr 2, 2025, 4:05 PM EDT - 23 days ago

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

Mar 26, 2025, 5:00 PM EDT - 4 weeks ago

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

Feb 21, 2025, 4:05 PM EST - 2 months ago

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.